E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/2/2006 in the Prospect News Biotech Daily.

Jefferies rates PDI at hold

PDI, Inc. was rated at hold by Jefferies & Co., Inc. analyst David Windley. The company reported first-quarter earnings per share of $0.40, compared with Jefferies' $0.05 estimate, despite posting lower revenue sequentially. PDI's gross margin improved in both segments and restructuring efforts reduced overhead costs. Cash flow from operations of $5 million brought PDI's net cash to $7.24 per share. Shares of the Saddle River, N.J., pharmaceutical services company were up 34 cents, or 2.72%, at $12.82 on volume of 142,733 shares versus the three-month running average of 93,304 shares. (Nasdaq: PDII)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.